Trials / Terminated
TerminatedNCT01144858
Clinical Value of Left Atrial Appendage Flow for Prediction of Successful Catheter Ablation for Persistent Atrial Fibrillation
- Status
- Terminated
- Phase
- —
- Study type
- Observational
- Enrollment
- 40 (actual)
- Sponsor
- Clinique Pasteur · Academic / Other
- Sex
- All
- Age
- 18 Years – 80 Years
- Healthy volunteers
- —
Summary
The purpose of this study was to determine whether left atrial appendage flow velocity, as determined using trans esophageal echocardiography (TEE), predicts the outcome after catheter ablation of persistent Atrial fibrillation( pAF).
Detailed description
40 PAF patients underwent 3D mapping and ablation. A stepwise approach including circumferential pulmonary vein (PV) isolation, continuous complex-fractionated electrogram (CFE) ablation and linear ablation was performed by the same operator. The procedural end point was termination of persistent AF by catheter ablation, either by conversion directly to sinus rhythm or to atrial tachycardia. Left atrial appendage (LAA) peak flow velocities were measured with transesophageal echography and averaged within each RR interval of 10 consecutive cardiac cycles.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | a complete transesophageal echocardiography | All patients were evaluated by a complete transesophageal echocardiography with multiplane probes with a 7-MHz transducer before catheter ablation .LA appendage flow was obtained by placing the pulsed Doppler sample volume at the orifice of the LA appendage, after which peak flow velocities were measured and averaged within each RR interval of 10 consecutive cardiac cycles |
Timeline
- Start date
- 2009-01-01
- Completion
- 2009-12-01
- First posted
- 2010-06-16
- Last updated
- 2010-06-16
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT01144858. Inclusion in this directory is not an endorsement.